deferoxamine has been researched along with ochratoxin a in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dirheimer, G; Obrecht-Pflumio, S | 1 |
Boesch-Saadatmandi, C; Ciesla, M; Dulak, J; Jozkowicz, A; Kozakowska, M; Loboda, A; Rimbach, G; Stachurska, A; Wolffram, S | 1 |
2 other study(ies) available for deferoxamine and ochratoxin a
Article | Year |
---|---|
In vitro DNA and dGMP adducts formation caused by ochratoxin A.
Topics: Animals; Arachidonic Acid; Carcinogens; Chelating Agents; Chromatography; Deferoxamine; Deoxyguanine Nucleotides; DNA Adducts; Female; Kidney; Male; Mice; Microsomes; Microsomes, Liver; Mycotoxins; NADP; Nucleotides; Ochratoxins; Peroxidase; Rabbits; Spectrophotometry | 2000 |
Cross-talk between microRNAs, nuclear factor E2-related factor 2, and heme oxygenase-1 in ochratoxin A-induced toxic effects in renal proximal tubular epithelial cells.
Topics: Acetylcysteine; Animals; Antioxidants; Cells, Cultured; Deferoxamine; Epithelial Cells; Erythropoietin; Gene Expression Regulation; Heme Oxygenase-1; Kidney Tubules, Proximal; MicroRNAs; NF-E2-Related Factor 2; Ochratoxins; Reactive Oxygen Species; Signal Transduction; Swine; Transforming Growth Factor beta | 2013 |